Jiinshihoto may improve immunity by improving depression in patients with mild pulmonary Mycobacterium avium-intracellulare complex disease: a preliminary study
Authors:
Preprint
- 28 September 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: In Japan, pulmonary Mycobacterium avium-intracellulare complex (MAC) disease is highly prevalent. This study aimed to evaluate the efficacy of Jiinshihoto (JST) for treating pulmonary MAC disease. Methods: Twenty-four patients, not receiving standard treatment for pulmonary MAC disease, were enrolled in this study; of these, 21 patients (3 patients dropped out of the study) were eligible and selected to participate. They were administered JST (3.0 g; Tsumura Co., Tokyo, Japan) three times per day for 12 months. Their weight, chronic obstructive pulmonary disease assessment test (CAT) score, NK cell activity, chest computed tomography (CT) results, blood sample results, Self-rating Depression Scale (SDS) scores, and State-Trait Anxiety Inventory (STAI) scores were measured: (i) before JST administration, (ii) after 3 months, and (iii) at the end of the study. Results: Before JST administration, the exacerbation group (n = 10 patients; 6 patients with worsened conditions at the end of the study and 4 patients who were switched to standard treatment during the study because of exacerbation) had a significantly low body mass index (BMI), mild depression, and high anxiety. The overall patient population showed no significant differences in the chronic obstructive pulmonary disease assessment score, body weight, or natural killer cell activity after 3 months of treatment; however, the SDS score improved significantly. At the end of treatment, the nutritional scores had worsened, but the SDS score improved significantly. Specifically, the SDS scores improved significantly only in the non-exacerbation group (n = 11 patients), and natural killer cell activity improved in the non-exacerbation group. Additionally, a comparison of the data of both groups before and after JST administration showed that the exacerbation group had significantly lower BMI and worse CT scores when using a BMI cutoff of 18.4 (sensitivity, 81.8%; specificity, 70%). Conclusion: Patients with a high BMI and low CT score at the time of initial diagnosis may benefit from JST treatment, which may significantly improve depression and immunity and prevent disease progression. Therefore, JST may be an effective treatment in selected pulmonary MAC patients. Trial registration: This study has been registered in the UMIN-Clinical Trials Registry (UMIN000033590, August 1, 2018).Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- The antidepressant-like effects of paeoniflorin in mouse modelsExperimental and Therapeutic Medicine, 2013
- Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD ExacerbationsAmerican Journal of Respiratory and Critical Care Medicine, 2012
- In vitro activities of natural products against oral Candida isolates from denture wearersBMC Complementary and Alternative Medicine, 2011
- Creating scenarios of the impact of copd and their relationship to copd assessment test (CAT™) scoresBMC Pulmonary Medicine, 2011
- Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expressionBreast Cancer Research and Treatment, 2010
- Inhibitory effects of steroidal timosaponins isolated from the rhizomes ofAnemarrhena asphodeloidesagainst passive cutaneous anaphylaxis reaction and pruritusImmunopharmacology and Immunotoxicology, 2010
- Development and first validation of the COPD Assessment TestEuropean Respiratory Journal, 2009
- Clinical Indications of JiinshihotoKampo Medicine, 2006
- Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus VectorJournal of Biological Chemistry, 1996
- ANTIINFLAMMATORY PRINCIPLES OFCAESALPINIA SAPPANWOOD AND OFHAEMATOXYLON CAMPECHIANUMWOOD1Planta Medica, 1977